TAK-228 (formerly MLN0128), an investigational dual TORC1/2 inhibitor plus paclitaxel, with/without trastuzumab, in patients with advanced solid malignancies
Titel:
TAK-228 (formerly MLN0128), an investigational dual TORC1/2 inhibitor plus paclitaxel, with/without trastuzumab, in patients with advanced solid malignancies
Auteur:
Burris, Howard A. Kurkjian, C. D. Hart, L. Pant, S. Murphy, P. B. Jones, S. F. Neuwirth, R. Patel, C. G. Zohren, F. Infante, J. R.